Lipoprotein(a) and High‐Sensitivity C‐Reactive Protein Compound the Risk of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.124.035597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Wence Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease Chinese Academy of Medical Science and Peking Union Medical Coll…. Hauptthemen laut MEDLINE: C-Reactive Protein, Transcatheter Aortic Valve Replacement, Lipoprotein(a), Aortic Valve Stenosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The mechanism for hypoattenuating leaflet thickening (HALT) after transcatheter aortic valve replacement is still not well elucidated, and the role of Lp(a) (lipoprotein[a]) and hs‐CRP (high‐sensitivity C‐reactive protein) has rarely been studied. This study sought to test the hypothesis that the risk of HALT is associated with an elevated level of Lp(a) or hs‐CRP. Methods and Results A total of 307 consecutive individuals who underwent a transcatheter aortic valve replacement procedure were included. All patients received their first postoperative computed tomography scans within 12 months, and raw data were analyzed on 3mensio software. HALT was defined as visually identified increased leaflet thickness with typical meniscal appearance and at least 2 different multiplanar reformation projections. Associations of Lp(a) or hs‐CRP with the risk of HALT were evaluated using multivariable logistic regression analysis. The incidence of HALT within 12 months after transcatheter aortic valve replacement in this study was 36.2%, and the risk of HALT was associated with higher baseline Lp(a) (the multivariable adjusted odds ratio [OR] for every 10 mg/dL change was 1.18 [95% CI, 1.09–1.29]) and hs‐CRP level (the multivariable adjusted OR for every 1 mg/L change was 1.08 [95% CI, 1.00–1.27]). Compared with individuals out of the top 25th percentile for both Lp(a) and hs‐CRP, the multivariable adjusted OR for HALT was 4.74 (95% CI, 1.65–14.37) for the top 25th percentile. This result remained consistent after excluding patients receiving anticoagulant therapy.
Conclusions
The top 25th percentile of Lp(a) level (≥40 mg/dL) combined with the top 25th percentile of hs‐CRP level (≥3.5 mg/L) conferred a 4.74‐fold risk of HALT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease Chinese Academy of Medical Science and Peking Union Medical College Beijing China.
ORCID-Profile: Wence Shi, Xiangming Hu, Can Wang, Yongjian Wu
Zitieren
APA
Shi, W., Feng, D., Hu, X., Wang, C., Niu, G., Zhao, Z., Zhang, H., Wang, M., & Wu, Y. (2024). Lipoprotein(a) and High‐Sensitivity C‐Reactive Protein Compound the Risk of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.035597
Vancouver
Shi W, Feng D, Hu X, Wang C, Niu G, Zhao Z, et al. Lipoprotein(a) and High‐Sensitivity C‐Reactive Protein Compound the Risk of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.035597
BibTeX
@article{Shi2024,
author = {Shi, Wence and Feng, Dejing and Hu, Xiangming and Wang, Can and Niu, Guannan and Zhao, Zhenyan and Zhang, Hongliang and Wang, Moyang and Wu, Yongjian},
title = {Lipoprotein(a) and High‐Sensitivity C‐Reactive Protein Compound the Risk of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.124.035597}
}
EUVIMED